Giuseppe Colloca
Overview
Explore the profile of Giuseppe Colloca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perri G, French C, Agostinis-Sobrinho C, Anand A, Antarianto R, Arai Y, et al.
J Gerontol A Biol Sci Med Sci
. 2024 Dec;
PMID: 39708300
Biomarkers of ageing serve as important outcome measures in longevity-promoting interventions. However, there is limited consensus on which specific biomarkers are most appropriate for human intervention studies. This work aimed...
2.
Roca E, Colloca G, Lombardo F, Bellieni A, Cucinella A, Madonia G, et al.
Oncotarget
. 2024 May;
15:345-353.
PMID: 38781107
In the landscape of cancer treatments, the efficacy of coadjuvant molecules remains a focus of attention for clinical research with the aim of reducing toxicity and achieving better outcomes. Most...
3.
Russo C, Mislang A, Ferraioli D, Soto-Perez-de-Celis E, Colloca G, Williams G, et al.
J Geriatr Oncol
. 2023 Jul;
14(6):101564.
PMID: 37393123
No abstract available.
4.
Rembielak A, Yau T, Akagunduz B, Aspeslagh S, Colloca G, Conway A, et al.
J Geriatr Oncol
. 2023 Apr;
14(4):101502.
PMID: 37080793
Introduction: Non-melanoma skin cancer (NMSC) is becoming ever more prevalent among older adults. However, older adults with NMSC are often underrepresented in clinical trials and guidelines on effective management is...
5.
Colloca G, Venturino A, Guarneri D
Expert Rev Anticancer Ther
. 2023 Mar;
23(4):421-429.
PMID: 36970998
Background: Neutrophil-to-lymphocyte ratio is suggested as a prognostic and predictive factor for patients with rectal cancer. The purpose of the current meta-analysis is to evaluate the relationship between neutrophil-lymphocyte ratio...
6.
Soto-Perez-de-Celis E, Mislang A, Hernandez-Favela C, Russo C, Colloca G, Williams G, et al.
J Geriatr Oncol
. 2022 Jul;
13(7):1054-1057.
PMID: 35853816
No abstract available.
7.
Federico A, Fragomeni S, Tagliaferri L, Guajardo Rios L, Lancellotta V, Gentileschi S, et al.
Int J Gynecol Cancer
. 2021 Dec;
32(2):127-132.
PMID: 34903559
Background: 'Severe acute respiratory syndrome coronavirus-2' (SARS-CoV-2) infection has dramatically affected the management of patients with cancer, who are most vulnerable to the consequences of the infection. Patients with vulvar...
8.
Colloca G, Venturino A
Pancreas
. 2021 Oct;
50(8):1131-1136.
PMID: 34714276
Systemic inflammatory response (SIR) plays a central role in the prognosis of unresectable or metastatic pancreatic ductal adenocarcinoma (mPDAC), and many SIR-related peripheral blood cell (PBC)-derived variables have been proposed...
9.
Colloca G
Asia Pac J Clin Oncol
. 2021 Jun;
18(3):232-239.
PMID: 34161667
For patients with unresectable or metastatic pancreatic adenocarcinoma (mPDAC), there are no standardized prognostic and predictive factors beyond performance status (PS). A poor PS, as defined by Eastern Cooperative Oncology...
10.
Zilioli V, Albano D, Arcari A, Merli F, Coppola A, Besutti G, et al.
J Cachexia Sarcopenia Muscle
. 2021 Jun;
12(4):1042-1055.
PMID: 34114749
Background: Elderly classical Hodgkin lymphoma (cHL) (ecHL) is a rare disease with dismal prognosis and no standard treatment. Fitness-based approaches may help design appropriate treatments. Sarcopenia has been associated with...